78 related articles for article (PubMed ID: 12646964)
1. Expression of the two alternative [a] and [b] transcripts of CCND1 gene in cyclin D1-expressing B-malignancies: relevance for the pathogenesis.
Roué G; Krieger S; Florent M; Roussel M; Duquesne F; Troussard X; Pichereau V; Sola B
Leukemia; 2003 Mar; 17(3):652-5. PubMed ID: 12646964
[No Abstract] [Full Text] [Related]
2. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
3. The relative levels of cyclin D1a and D1b alternative transcripts in mantle cell lymphoma may depend more on sample origin than on CCND1 polymorphism.
Carrère N; Belaud-Rotureau MA; Dubus P; Parrens M; de Mascarel A; Merlio JP
Haematologica; 2005 Jun; 90(6):854-6. PubMed ID: 15951302
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 expression in B-cell lymphomas.
Gladkikh A; Potashnikova D; Korneva E; Khudoleeva O; Vorobjev I
Exp Hematol; 2010 Nov; 38(11):1047-57. PubMed ID: 20727381
[TBL] [Abstract][Full Text] [Related]
5. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CI; Sander B
Leukemia; 2003 Sep; 17(9):1880-90. PubMed ID: 12970790
[TBL] [Abstract][Full Text] [Related]
6. The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241.
Howe D; Lynas C
Haematologica; 2001 Jun; 86(6):563-9. PubMed ID: 11418364
[TBL] [Abstract][Full Text] [Related]
7. Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.
Thomázy VA; Luthra R; Uthman MO; Davies PJ; Medeiros LJ
J Mol Diagn; 2002 Nov; 4(4):201-8. PubMed ID: 12411587
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia.
Derksen PW; Langerak AW; Kerkhof E; Wolvers-Tettero IL; Boor PP; Mulder AH; Vrints LW; Coebergh JW; van Krieken JH; Schuuring E; Kluin PM; van Dongen JJ
Mod Pathol; 1999 Aug; 12(8):794-805. PubMed ID: 10463482
[TBL] [Abstract][Full Text] [Related]
9. A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3' enhancers does not promote by itself B-cell malignancies.
Fiancette R; Amin R; Truffinet V; Vincent-Fabert C; Cogné N; Cogné M; Denizot Y
Leuk Res; 2010 Aug; 34(8):1043-51. PubMed ID: 20018375
[TBL] [Abstract][Full Text] [Related]
10. In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.
Athanasiou E; Kotoula V; Hytiroglou P; Kouidou S; Kaloutsi V; Papadimitriou CS
Mod Pathol; 2001 Feb; 14(2):62-71. PubMed ID: 11235907
[TBL] [Abstract][Full Text] [Related]
11. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation.
Lukas J; Jadayel D; Bartkova J; Nacheva E; Dyer MJ; Strauss M; Bartek J
Oncogene; 1994 Aug; 9(8):2159-67. PubMed ID: 8036001
[TBL] [Abstract][Full Text] [Related]
12. Real-time RT-PCR assay for quantifying cyclin D1 mRNA in B-cell non-Hodgkin's lymphomas.
Medeiros LJ; Hai S; Thomazy VA; Estalilla OC; Romaguera J; Luthra R
Mod Pathol; 2002 May; 15(5):556-64. PubMed ID: 12011261
[TBL] [Abstract][Full Text] [Related]
13. A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas.
Belaud-Rotureau MA; Parrens M; Dubus P; Garroste JC; de Mascarel A; Merlio JP
Mod Pathol; 2002 May; 15(5):517-25. PubMed ID: 12011256
[TBL] [Abstract][Full Text] [Related]
14. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD
Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438
[TBL] [Abstract][Full Text] [Related]
15. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
16. Determination of cyclin d1 expression by quantitative real-time, reverse-transcriptase polymerase chain reaction.
Bijwaard KE; Lichy JH
Methods Mol Med; 2004; 97():277-95. PubMed ID: 15064500
[No Abstract] [Full Text] [Related]
17. A review of the association between interleukin-10 and human B-cell malignancies.
Khatri VP; Caligiuri MA
Cancer Immunol Immunother; 1998 Jul; 46(5):239-44. PubMed ID: 9690451
[No Abstract] [Full Text] [Related]
18. Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells.
Dhar KK; Branigan K; Parkes J; Howells RE; Hand P; Musgrove C; Strange RC; Fryer AA; Redman CW; Hoban PR
Br J Cancer; 1999 Dec; 81(7):1174-81. PubMed ID: 10584879
[TBL] [Abstract][Full Text] [Related]
19. Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction.
Naji A; Menier C; Maki G; Carosella ED; Rouas-Freiss N
Leukemia; 2012 Aug; 26(8):1889-92. PubMed ID: 22441169
[No Abstract] [Full Text] [Related]
20. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.
Evans PA; Pott Ch; Groenen PJ; Salles G; Davi F; Berger F; Garcia JF; van Krieken JH; Pals S; Kluin P; Schuuring E; Spaargaren M; Boone E; González D; Martinez B; Villuendas R; Gameiro P; Diss TC; Mills K; Morgan GJ; Carter GI; Milner BJ; Pearson D; Hummel M; Jung W; Ott M; Canioni D; Beldjord K; Bastard C; Delfau-Larue MH; van Dongen JJ; Molina TJ; Cabeçadas J
Leukemia; 2007 Feb; 21(2):207-14. PubMed ID: 17170731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
